Core Viewpoint - The company has achieved a significant legal victory regarding its original research product Budesonide Enteric-Coated Capsules (Nai Fukan®), with the Guangzhou Intellectual Property Court ruling in favor of the company's request for pre-litigation preservation of rights, ordering related generic drug companies to cease infringement activities and stop listing the product [1] Group 1 - The Guangzhou Intellectual Property Court issued a civil ruling on February 26, 2026, fully supporting the company's pre-litigation preservation application [1] - The court's ruling mandates that relevant generic drug companies immediately stop infringing activities and cease product listings [1] - The ruling is effective immediately upon issuance [1]
云顶新耀：耐赋康®专利诉讼取得积极进展